Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Pediatr. 2016 Sep 9;179:226–232. doi: 10.1016/j.jpeds.2016.08.041

Table 4.

Predictors of vaccination in children exposed to chronic glucocorticoid therapy

Influenza Vaccine Pneumococcal Polysaccharide Vaccine
Variable Univariate OR
(95% CI)
p Multivariate OR
(95% CI)
p Univariate OR
(95% CI)
p Multivariate OR
(95% CI)
p
Age, years(baseline) 0.87 (0.79, 0.97) 0.01 0.87 (0.78, 0.96) 0.008 0.91 (0.88, 0.95) <0.001 0.94 (0.89, 0.99) 0.02
Follow up duration, months 0.97. (0.91, 1.03) 0.29 0.96 (0.89, 1.03) 0.22 1.03 (1.00, 1.05) 0.05 1.01 (0.98, 1.04) 0.52
Sex, Male 1.82 (0.77, 4.32) 0.18 -- -- 1.18 (0.79, 1.76) 0.43 -- --
Race, Non-White 0.89 (0.37, 2.10) 0.78 -- -- 2.78 (1.84, 4.20) <0.001 1.72 (1.03, 2.89) 0.04
Hispanic Ethnicity 0.75 (0.18, 3.21) 0.70 -- -- 0.73 (0.34, 1.58) 0.43 -- --
Non-Private Insurance 0.71 (0.30, 1.69) 0.44 -- -- 2.20 (1.43, 3.39) <0.001 -- --
Height Z-Score, SD
(baseline)
0.81 (0.59, 1.12) 0.21 -- -- 0.96 (0.82, 1.13) 0.62 -- --
BMI Z-Score, SD (baseline) 0.85 (0.63, 1.15) 0.30 -- -- 1.37 (1.14, 1.63) 0.001 -- --
In Network Care N/A N/A N/A N/A 2.90 (1.87, 4.49) <0.001 3.48 (1.91, 6.35) <0.001
GC Cumulative Dose
Quartile
 1 Reference -- Reference -- Reference Reference --
 2 0.34 (0.08, 1.42) 0.14 -- -- 1.33 (0.63, 2.83) 0.46 1.18 (0.50, 2.80) 0.70
 3 0.47 (0.12, 1.76) 0.26 -- -- 2.18 (1.08, 4.39) 0.03 1.68 (0.75, 3.73) 0.21
 4 0.5 (0.14, 1.83) 0.30 -- -- 5.68 (2.97, 10.86) <0.001 2.67 (1.24, 5.78) 0.01
Subspecialty
 Gastroenterology Reference -- -- -- Reference -- Reference --
 Nephrology 1.33 (0.80, 2.21) 0.27 1.14 (0.43, 3.01) 0.79 30.37 (14.82, 62.24) <0.001 28.72 (13.34, 61.84) <0.001
 Rheumatology 0.70 (0.36, 1.38) 0.31 2.06 (0.38, 11.05) 0.40 4.18 (1.77, 9.90) 0.001 4.77 (1.92, 11.84) 0.001

The multivariate model for influenza vaccine included: Age, Follow-Up Time, Specialty. The multivariate model for pneumococcal polysaccharide vaccine: Age, Follow-Up Time, Race, In Network, GC Cumulative Dose Quartile, Specialty